Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening studies.
Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Eržen M, Juschenko A, Costa S, Sarian L, Podistov J, Syrjänen S; NIS and LAMS Study Research Groups. Syrjänen K, et al. Among authors: shabalova i. Int J STD AIDS. 2011 Jun;22(6):315-23. doi: 10.1258/ijsa.2009.009365. Int J STD AIDS. 2011. PMID: 21680666
Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union.
Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Cintorino M, Santopietro R, Tosi P, Syrjänen K. Syrjänen S, et al. Among authors: shabalova i. Eur J Gynaecol Oncol. 2005;26(5):491-8. Eur J Gynaecol Oncol. 2005. PMID: 16285563
Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women.
Syrjänen K, Kulmala SM, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunjberga V, Grunjberg A, Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjänen S. Syrjänen K, et al. Among authors: shabalova i. Eur J Gynaecol Oncol. 2008;29(2):114-22. Eur J Gynaecol Oncol. 2008. PMID: 18459542
Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
Syrjänen K, Shabalova I, Naud P, Derchain S, Sarian L, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Hammes LS, Costa S, Podistov J, Syrjänen S; NIS and the LAMS Study Research Groups; Analysis of the combined prospective cohort of the NIS; LAMS Studies. Syrjänen K, et al. Among authors: shabalova i. Int J STD AIDS. 2011 May;22(5):263-72. doi: 10.1258/ijsa.2009.009280. Int J STD AIDS. 2011. PMID: 21571974
Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
Syrjänen K, Shabalova I, Sarian L, Naud P, Longatto-Filho A, Derchain S, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Serpa Hammes L, Podistov J, Costa S, Syrjänen S; NIS Study Research Group; LAMS Study Research Group. Syrjänen K, et al. Among authors: shabalova i. Eur J Gynaecol Oncol. 2012;33(1):5-14. Eur J Gynaecol Oncol. 2012. PMID: 22439398
Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the NIS-LAMS cohort.
Syrjänen K, Shabalova I, Sarian L, Naud P, Longatto-Filho A, Derchain S, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Hammes LS, Podistov J, Costa S, Syrjänen S; NIS Study Research Group; LAMS Study Research Group. Syrjänen K, et al. Among authors: shabalova i. Eur J Gynaecol Oncol. 2012;33(4):341-52. Eur J Gynaecol Oncol. 2012. PMID: 23091888
Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study).
Syrjänen S, Shabalova IP, Petrovichev N, Kozachenko VP, Zakharova T, Pajanidi A, Podistov JI, Chemeris G, Sozaeva LG, Lipova EV, Tsidaeva I, Ivanchenko OG, Pshepurko AA, Zakharenko S, Nerovjna R, Kljukina LB, Erokhina OA, Branovskaja MF, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen KJ. Syrjänen S, et al. Among authors: shabalova ip. Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):219-27. doi: 10.1016/j.ejogrb.2004.07.036. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 15808384
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.
Kulmala SM, Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Grunberga V, Juschenko A, Tosi P, Santopietro R, Syrjänen K. Kulmala SM, et al. Among authors: shabalova i. J Clin Microbiol. 2004 Jun;42(6):2470-5. doi: 10.1128/JCM.42.6.2470-2475.2004. J Clin Microbiol. 2004. PMID: 15184422 Free PMC article.
67 results